Drugs / MK0653A
last change Jun 2003 re-read 3 minutes ago

MK0653A

Developed for
hyperlipidemia
Investigated by
Organon and Co

Trials 1

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00092651 Sep 2002 → Jun 2003 hyperlipidemia Organon and Co Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MK0653A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00092651 ↗